当前位置:首页 - 行情中心 - 正海生物(300653) - 财务分析

正海生物

(300653)

  

流通市值:40.77亿  总市值:40.77亿
流通股本:1.80亿   总股本:1.80亿

正海生物(300653)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2023年年度实现净利润1.91亿元,每股收益1.06元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2023年年度最新股东权益94806.54万元,未分配利润49944.48万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2023年年度最新总资产105382.46万元,负债10575.93万元。

利润表
报告期2023-12-312023-09-302023-06-302023-03-31
营业总收入413,652,710.67321,781,527.57224,505,570.6109,080,515.27
营业总成本222,461,772.96172,703,380.33114,279,069.4255,350,360.81
营业利润218,570,970.3168,798,450.3125,018,056.0862,856,644.1
利润总额218,396,069.54168,883,417.38125,130,207.1962,851,447.98
净利润190,957,573.45148,335,221.24109,841,808.7253,398,823.33
其他综合收益----
综合收益总额190,957,573.45148,335,221.24109,841,808.7253,398,823.33
资产负债表
报告期2023-12-312023-09-302023-06-302023-03-31
流动资产合计770,633,742.64721,786,720.43690,251,925.02747,503,222.35
非流动资产合计283,190,886.03267,422,038.63264,611,311.01272,406,667.42
资产总计1,053,824,628.67989,208,759.06954,863,236.031,019,909,889.77
流动负债合计90,002,949.6768,038,407.9972,014,985.3885,361,838.76
非流动负债合计15,756,313.915,727,338.1815,898,650.2816,041,436.03
负债合计105,759,263.5783,765,746.1787,913,635.66101,403,274.79
归属于母公司股东权益合计948,065,365.1905,443,012.89866,949,600.37918,506,614.98
股东权益合计948,065,365.1905,443,012.89866,949,600.37918,506,614.98
负债和股东权益合计1,053,824,628.67989,208,759.06954,863,236.031,019,909,889.77
现金流量表
报告期2023-12-312023-09-302023-06-302023-03-31
经营活动现金流入小计438,424,316.82327,349,844.73224,944,602115,002,511.65
经营活动现金流出小计257,946,503.46200,631,508.73135,739,341.2563,589,855.44
经营活动产生的现金流量净额180,477,813.36126,718,33689,205,260.7551,412,656.21
投资活动现金流入小计1,130,954,776.88938,931,632.29640,394,966.45407,569,073.84
投资活动现金流出小计1,201,906,308.09895,229,255.97577,306,748.87324,496,946.97
投资活动产生的现金流量净额-70,951,531.2143,702,376.3263,088,217.5883,072,126.87
筹资活动现金流入小计----
筹资活动现金流出小计108,005,137.04108,000,000108,000,000-
筹资活动产生的现金流量净额-108,005,137.04-108,000,000-108,000,000-
汇率变动对现金及现金等价物的影响----
现金及现金等价物净增加额1,521,145.1162,420,712.3244,293,478.33134,484,783.08
期末现金及现金等价物余额58,566,767.9119,466,335.11101,339,101.12191,530,405.87
最新报告期:2024-04-03
研究机构分析师预测每股收益(元)更新日
2023年2024年2025年
中金公司全芳,朱言音1.201.45--2024-04-03
华泰证券代雯,孔垂岩,王殷杰1.241.521.832024-04-02
东吴证券朱国广1.261.531.822024-04-02
TOP↑